Search results
Showing 451 to 465 of 1251 results for public health guidance
Biographies and registered interests for members of the Technology Appraisal Committee A
Awaiting development Reference number: GID-TA11224 Expected publication date: TBC
Awaiting development Reference number: GID-TA11342 Expected publication date: TBC
Awaiting development Reference number: GID-TA11094 Expected publication date: TBC
This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis. It aims to improve the physical and mental health and quality of life of people with faecal incontinence.
Awaiting development Reference number: GID-TA11615 Expected publication date: TBC
Awaiting development Reference number: GID-TA11639 Expected publication date: TBC
In development Reference number: GID-TA11052 Expected publication date: TBC
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
In development Reference number: GID-TA11036 Expected publication date: TBC
Pimicotinib for treating tenosynovial giant cell tumours when systemic treatment is needed [ID6647]
In development Reference number: GID-TA11859 Expected publication date: TBC
Awaiting development Reference number: GID-TA11716 Expected publication date: TBC
Navepegritide for treating achondroplasia in people 2 to 15 years [ID6538]
Awaiting development Reference number: GID-TA11699 Expected publication date: TBC
Awaiting development Reference number: GID-TA11695 Expected publication date: TBC
Awaiting development Reference number: GID-TA11583 Expected publication date: TBC